Abstract
Cellular senescence is widely believed to play a key role in tumor suppression, but the molecular pathways that regulate senescence are only incompletely understood. By using a secretome proteomics approach, we identified insulin-like growth factor binding protein 3 (IGFBP3) as a secreted mediator of breast cancer senescence upon chemotherapeutic drug treatment. The senescenceinducing activity of IGFBP3 is inhibited by tissue-type plasminogen activator-mediated proteolysis, which is counteracted by plasminogen activator inhibitor 1 (PAI-1), another secreted mediator of senescence. We demonstrate that IGFBP3 is a critical downstream target of PAI-1-induced senescence. These results suggest a role for an extracellular cascade of secreted proteins in the regulation of cellular senescence.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 12052-12057 |
| Number of pages | 6 |
| Journal | Proceedings of the National Academy of Sciences of the United States of America |
| Volume | 109 |
| Issue number | 30 |
| DOIs | |
| State | Published - Jul 24 2012 |
Keywords
- Chemotherapy
- Isotope-coded affinity tag
- Protease
- Protease inhibitor
- Protein secretion
ASJC Scopus subject areas
- General
Fingerprint
Dive into the research topics of 'Plasminogen activator inhibitor 1 - Insulin-like growth factor binding protein 3 cascade regulates stress-induced senescence'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS